Vafseo Tablets 300mg, containing Vadadustat, is manufactured by Mitsubishi Tanabe Pharma (YJ code: 3999050F2026, standard: 300mg 1 tablet). Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor used for the treatment of anemia in adults with chronic kidney disease (CKD) who are on dialysis. It acts to increase the body’s red blood cell production.
Vafseo Tablets 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →